Omega-3 EPA/DHA supplement science abstracts related to diabetes and pre-diabetes metabolic syndrome.
Go to PubMed and copy the title in the search field.
Effects of eicosapentaenoic acid and vitamin C on glycemic indices, blood pressure, and serum lipids in type 2 diabetic Iranian males.
5-Hydroxy-eicosapentaenoic acid is an endogenous GPR119 agonist and enhances glucose-dependent insulin secretion.
Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status.
The Effects of Low Dose n-3 Fatty Acids on Serum Lipid Profiles and Insulin Resistance of the Elderly: a Randomized Controlled Clinical Trial.
Adipose tissue fatty acids and insulin sensitivity in elderly men.
Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus.
Fatty acids and obesity.
Highly purified eicosapentaenoic acid ethyl ester prevents development of steatosis and hepatic fibrosis in rats.
The role of polyunsaturated fatty acids (PUFA) in the treatment of dyslipidemias.
Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study.
Prevention of insulin resistance by n-3 polyunsaturated fatty acids.
Increased selenium intake in elderly high fish consumers may account for health benefits previously ascribed to omega-3 fatty acids.
N-3 polyunsaturated fatty acids modulate in-vitro T cell function in type I diabetic patients.
Can essential fatty acids reduce the burden of disease(s)?
Metabolic syndrome (does it have a common denominator?).
Lipid, glycemic, and insulin responses to meals rich in saturated, cis-monounsaturated, and polyunsaturated (n-3 and n-6) fatty acids in subjects with type 2 diabetes.
Omega-6 and omega-3 fatty acids predict accelerated decline of peripheral nerve function in older persons.
n-3 fatty acids and the metabolic syndrome.
Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review.
Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects.
Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy.
Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus. Effect of omega-3 fatty acids.
Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients.
Eicosapentaenoic acid improves endothelial function in hypertriglyceridemic subjects despite increased lipid oxidizability.
Platelet aggregation in non-insulin-dependent diabetes is associated with platelet fatty acids.